Published in ASAIO J on April 23, 2015
Endocarditis due to Gemella haemolysans in a newly diagnosed multiple myeloma patient. J Community Hosp Intern Med Perspect (2016) 0.75
Infective endocarditis in adults. N Engl J Med (2001) 9.95
Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med (2009) 7.82
Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis (2010) 3.84
Antimicrobial susceptibility of Gemella haemolysans isolated from patients with subacute endocarditis. Eur J Clin Microbiol (1982) 2.01
Experience with more than 100 total artificial heart implants. J Thorac Cardiovasc Surg (2012) 1.73
Molecular diagnosis of infective endocarditis by real-time broad-range polymerase chain reaction (PCR) and sequencing directly from heart valve tissue. Medicine (Baltimore) (2007) 1.41
Total artificial heart bridge to transplantation: a 9-year experience with 62 patients. J Heart Lung Transplant (2004) 1.25
Management of prosthetic valve infective endocarditis. Am J Cardiol (2008) 1.08
The role of valve surgery in infective endocarditis management: a systematic review of observational studies that included propensity score analysis. Am Heart J (2008) 1.07
Subacute endocarditis caused by Gemella haemolysans and a review of the literature. Scand J Infect Dis (2004) 0.98
Veno-venous extracorporeal membrane oxygenation with a bicaval dual-lumen catheter in a SynCardia total artificial heart patient. J Cardiothorac Surg (2013) 0.97
Prosthetic valve endocarditis. J Cardiovasc Med (Hagerstown) (2010) 0.94
SynCardia temporary total artificial heart as bridge to transplantation: current results at la pitié hospital. Ann Thorac Surg (2013) 0.94
Allograft aortic root replacement in complex prosthetic endocarditis. Eur J Cardiothorac Surg (2007) 0.87
Current issues in the diagnosis and management of blood culture-negative infective and non-infective endocarditis. Ann Thorac Surg (2013) 0.80
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 11.88
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation (2013) 10.07
2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation (2013) 3.86
Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation (2012) 3.24
Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure. JAMA (2008) 3.01
Clinical experience with linezolid for the treatment of nocardia infection. Clin Infect Dis (2003) 2.37
Multicenter evaluation of an intrapericardial left ventricular assist system. J Am Coll Cardiol (2011) 2.22
Prediction of mode of death in heart failure: the Seattle Heart Failure Model. Circulation (2007) 2.22
Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE). J Am Coll Cardiol (2003) 2.10
Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation (2009) 2.02
Utility of the Seattle Heart Failure Model in patients with advanced heart failure. J Am Coll Cardiol (2009) 1.98
High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure. Circ Heart Fail (2010) 1.96
Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial. Eur J Heart Fail (2012) 1.76
The influence of age, gender, and training on exercise efficiency. J Am Coll Cardiol (2006) 1.71
Time-dependent Predictive Values of Prognostic Biomarkers with Failure Time Outcome. J Am Stat Assoc (2008) 1.65
Multiple biomarkers for risk prediction in chronic heart failure. Circ Heart Fail (2012) 1.57
Prospective trial of a blood supply-based technique of pancreaticojejunostomy: effect on anastomotic failure in the Whipple procedure. J Am Coll Surg (2002) 1.55
Selective improvement in Seattle Heart Failure Model risk stratification using iodine-123 meta-iodobenzylguanidine imaging. J Nucl Cardiol (2012) 1.51
Long-term outcome for the surgical treatment of infective endocarditis with a focus on intravenous drug users. Ann Thorac Surg (2011) 1.49
Changing volumes, risk profiles, and outcomes of coronary artery bypass grafting and percutaneous coronary interventions. Ann Thorac Surg (2009) 1.45
Biomechanical efficiency is impaired in patients with chronic heart failure. Eur J Heart Fail (2007) 1.41
Comparison of observed survival after ventricular assist device placement versus predicted survival without assist device using the Seattle heart failure model. ASAIO J (2012) 1.39
Linezolid-induced lactic acidosis. N Engl J Med (2003) 1.24
trans fatty acids and systemic inflammation in heart failure. Am J Clin Nutr (2004) 1.17
Evaluating the ROC performance of markers for future events. Lifetime Data Anal (2007) 1.16
Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. J Am Coll Cardiol (2006) 1.12
Application of the Seattle Heart Failure Model in ambulatory patients presented to an advanced heart failure therapeutics committee. Circ Heart Fail (2010) 1.11
Optimal immunosuppression for HIV-positive kidney transplants: long-term randomized controlled trials needed. Transplantation (2014) 1.08
Statin therapy is associated with lower mortality among patients with severe heart failure. Am J Cardiol (2004) 1.06
Effects of aging on cardiovascular responses to parasympathetic withdrawal. J Am Coll Cardiol (2003) 1.04
The vascular marker soluble fms-like tyrosine kinase 1 is associated with disease severity and adverse outcomes in chronic heart failure. J Am Coll Cardiol (2011) 1.04
Summary health status measures in advanced heart failure: relationship to clinical variables and outcome. J Card Fail (2007) 1.02
Cytokines in depression and heart failure. Psychosom Med (2003) 1.01
Depression and health status in patients with advanced heart failure: a prospective study in tertiary care. J Card Fail (2004) 1.01
Usefulness of depression to predict time to combined end point of transplant or death for outpatients with advanced heart failure. Am J Cardiol (2004) 0.99
Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptide. Am J Cardiol (2007) 0.97
Transplant registrants with implanted left ventricular assist devices have insufficient risk to justify elective organ procurement and transplantation network status 1A time. J Am Coll Cardiol (2012) 0.97
Evidence for pre- to postsynaptic mismatch of the cardiac sympathetic nervous system in ischemic congestive heart failure. J Nucl Med (2008) 0.95
Important differences in mode of death between men and women with heart failure who would qualify for a primary prevention implantable cardioverter-defibrillator. Circulation (2012) 0.93
Safety and efficacy of the MitraClip® system for severe mitral regurgitation: a systematic review. Catheter Cardiovasc Interv (2014) 0.91
Predictive value of the Seattle Heart Failure Model in patients undergoing left ventricular assist device placement. J Heart Lung Transplant (2010) 0.90
The effects of atorvastatin (10 mg) on systemic inflammation in heart failure. Am J Cardiol (2005) 0.88
Exercise training and heart rate variability in older adult female subjects. Clin Invest Med (2006) 0.87
Fatigue, inflammation, and projected mortality in heart failure. J Card Fail (2012) 0.87
Associations between Seattle Heart Failure Model scores and health utilities: findings from HF-ACTION. J Card Fail (2013) 0.86
Usefulness of relative lymphocyte count as an independent predictor of death/urgent transplant in heart failure. Am J Cardiol (2005) 0.86
Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure. Am Heart J (2010) 0.85
Cost-consequences of ultrafiltration for acute heart failure: a decision model analysis. Circ Cardiovasc Qual Outcomes (2009) 0.85
Influence of predictive modeling in implementing optimal heart failure therapy. Am J Med Sci (2011) 0.85
Drifting in a shrinking future: living with advanced heart failure. J Cardiovasc Nurs (2007) 0.85
In patients with heart failure elevated soluble TNF-receptor 1 is associated with higher risk of depression. J Card Fail (2007) 0.82
Multivariate risk scores and patient outcomes in advanced heart failure. Congest Heart Fail (2011) 0.82
Potential clinical applications of the HeartMate II risk score. J Am Coll Cardiol (2012) 0.81
Oxygen cost of exercise is increased in heart failure after accounting for recovery costs. Chest (2003) 0.81
Usefulness of cardiac iodine-123 meta-iodobenzylguanidine imaging to improve prognostic power of Seattle heart failure model in patients with chronic heart failure. Am J Cardiol (2011) 0.80
Normal aging impairs upregulation of the beta-adrenergic but not the alpha-adrenergic response: aging and adrenergic upregulation. J Cardiovasc Pharmacol (2006) 0.80
A case of Ramsay Hunt-like syndrome caused by herpes simplex virus type 2. Clin Infect Dis (2005) 0.80
Association between bilirubin and mode of death in severe systolic heart failure. Am J Cardiol (2013) 0.79
Suppression of beta-catenin by antisense oligomers augments tumor response to isolated limb perfusion in a rodent model of adenomatous polyposis coli-mutant colon cancer. Ann Surg Oncol (2005) 0.78
Percutaneous coronary sinus catheterization for minimally invasive cardiac surgery--more questions than answers? J Cardiothorac Vasc Anesth (2010) 0.78
Genetic variants of the hemostatic system and development of transplant coronary artery disease. J Heart Lung Transplant (2002) 0.77
Multidrug-Resistant Corynebacterium striatum Associated with Increased Use of Parenteral Antimicrobial Drugs. Emerg Infect Dis (2016) 0.77
Quantitative Feedback Facilitates Acquisition of Skills in Focused Cardiac Ultrasound. Simul Healthc (2016) 0.76
The effect of aging on phenylephrine response in normal subjects. J Am Aging Assoc (2003) 0.76
The Joint Council on Thoracic Surgery Education coronary artery assessment tool has high interrater reliability. Ann Thorac Surg (2013) 0.76
Clonidine therapy in patients with heart failure improves exercise efficiency, functional class and symptoms. Int J Cardiol (2011) 0.76
Short-course isoniazid plus rifapentine directly observed therapy for latent tuberculosis in solid-organ transplant candidates. Transplantation (2014) 0.75
Widespread availability of artemisinin monotherapy in the United States. Emerg Infect Dis (2011) 0.75
Diabetes and heart failure: is insulin therapy the answer? J Am Coll Cardiol (2003) 0.75
The Seattle Post Myocardial Infarction Model (SPIM): prediction of mortality after acute myocardial infarction with left ventricular dysfunction. Eur Heart J Acute Cardiovasc Care (2013) 0.75
Seattle Heart Failure Model. Am J Cardiol (2013) 0.75
Activity, inhibition, and induction of cytochrome P450 2J2 in adult human primary cardiomyocytes. Drug Metab Dispos (2013) 0.75
Bicuspid aortic valve and aortopathy: see the first, then look at the second. JACC Cardiovasc Imaging (2013) 0.75
Transplant complications: the lesser of 2 evils. J Am Coll Cardiol (2011) 0.75
Anemia in heart failure: marker or mediator of adverse prognosis? J Am Coll Cardiol (2008) 0.75
Vaccination mandates vs opt-out programs and rates of influenza immunization. JAMA (2010) 0.75
Can B-type natriuretic peptides replace heart failure risk models? Eur J Heart Fail (2008) 0.75
Novel use of an apical-femoral wire rail to assist with transfemoral transcatheter aortic valve replacement. J Invasive Cardiol (2014) 0.75
Confirmation of Chagas' cardiomyopathy following heart transplantation. Heart Vessels (2006) 0.75
LVAD Outflow Graft Angle and Thrombosis Risk. ASAIO J (2016) 0.75
Self-administration education and polypharmacy in mechanical circulatory support patients. J Heart Lung Transplant (2013) 0.75
Comparison of the Seattle heart failure model and cardiopulmonary exercise capacity for prediction of death in patients with chronic ischemic heart failure and intracoronary progenitor cell application. Clin Cardiol (2013) 0.75
Impact of LVAD Implantation Site on Ventricular Blood Stagnation. ASAIO J (2016) 0.75
Long-Term Right Ventricular Assist Device Therapy in an Adult with Pulmonary Atresia/Intact Ventricular Septum. ASAIO J (2017) 0.75
Impact of Patient Distance From Ventricular Assist Device-Implanting Center on Short- and Long-Term Outcomes. ASAIO J (2017) 0.75
Successful management of asystole with an isolated left ventricular assist device. J Heart Lung Transplant (2006) 0.75
Clinical statement on the requirements for surgeon certification for implantation of durable Ventricular Assist Devices (VADs). Ann Thorac Surg (2013) 0.75
Echo simulator with novel training and competency testing tools. Stud Health Technol Inform (2013) 0.75
Gonococcal ascending aortitis with penetrating ulcers and intraluminal thrombus. Ann Thorac Surg (2011) 0.75
Case 3--2013: Maldistribution of cardioplegia detected by transesophageal echocardiography during minimally invasive cardiac surgery. J Cardiothorac Vasc Anesth (2013) 0.75
Scedosporium apiospermum otomycosis. Am J Otolaryngol (2007) 0.75
The role of norepinephrine in exercise impairment in congestive heart failure. Congest Heart Fail (2003) 0.75
Delayed complications from exposure to improvised explosive devices. Ann Intern Med (2010) 0.75
Lack of depression effect on platelet activation in patients with heart failure. Psychiatry Res (2004) 0.75
Performance of the Seattle Heart Failure Model in implantable defibrillator patients treated with cardiac resynchronization therapy. Am J Cardiol (2012) 0.75
Intermittent Aortic Valve Opening and Risk of Thrombosis in VAD Patients. ASAIO J (2017) 0.75